NCT00424619View on ClinicalTrials.gov

A Randomised, Controlled Comparison of Vitamin D Strategies is Acute Hip Fracture Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Hip Fracture
Interventions
DRUG

Vitamin D2

50 000 IU vitamin D2, one time bolus dose

DRUG

Vitamin D2

100 000 IU vitamin D2, one time bolus dose

DRUG

Placebo

Placebo, 1 time bolus dose

All Listed Sponsors
collaborator

Merck Frosst Canada Ltd.

INDUSTRY

lead

McMaster University

OTHER

NCT00424619 - A Randomised, Controlled Comparison of Vitamin D Strategies is Acute Hip Fracture Patients | Biotech Hunter | Biotech Hunter